Human cytomegalovirus persistence

Cellular Microbiology

Volumn 14, Issue 5, 2012, Pages 644-655

  Goodrum, Felicia ^a,b   Caviness, Katie ^b   Zagallo, Patricia ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; JANUS KINASE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; ROSCOVITINE; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; US28 PROTEIN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOSURVEILLANCE; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEROPREVALENCE; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS SHEDDING;

CHRONIC DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MODELS, BIOLOGICAL; VIRUS LATENCY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84859899584     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2012.01774.x     Document Type: Short Survey

References (123)

1. Ahn, J.H., and Hayward, G.S. (1997) The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71: 4599-4613.
2. Avdic, S., Cao, J.Z., Cheung, A.K., Abendroth, A., and Slobedman, B. (2011) Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol 85: 7465-7471.
3. Bego, M., Maciejewski, J., Khaiboullina, S., Pari, G., and St Jeor, S. (2005) Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 79: 11022-11034.
4. Bego, M.G., Keyes, L.R., Maciejewski, J., and St Jeor, S.C. (2011) Human cytomegalovirus latency-associated protein LUNA is expressed during HCMV infections in vivo. Arch Virol 156: 1847-1851.
5. Beisser, P.S., Laurent, L., Virelizier, J.L., and Michelson, S. (2001) Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol 75: 5949-5957.
6. Bell, P., Lieberman, P.M., and Maul, G.G. (2000) Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74: 11800-11810.
7. Bentz, G.L., and Yurochko, A.D. (2008) Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins. Proc Natl Acad Sci USA 105: 5531-5536.
8. Bieniasz, P.D. (2004) Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5: 1109-1115.
9. Bloom, D.C., Giordani, N.V., and Kwiatkowski, D.L. (2010) Epigenetic regulation of latent HSV-1 gene expression. Biochim Biophys Acta 1799: 246-256.
10. Boeckh, M., and Geballe, A.P. (2011) Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 121: 1673-1680.
11. Bongers, G., Maussang, D., Muniz, L.R., Noriega, V.M., Fraile-Ramos, A., Barker, N., etal. (2010) The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest 120: 3969-3978.
12. Britt, W. (2008) Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 325: 417-470.
13. Brune, W. (2011) Inhibition of programmed cell death by cytomegaloviruses. Virus Res 157: 144-150.
14. Cantrell, S.R., and Bresnahan, W.A. (2005) Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. J Virol 79: 7792-7802.
15. Cantrell, S.R., and Bresnahan, W.A. (2006) Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80: 6188-6191.
16. Chan, G., Bivins-Smith, E.R., Smith, M.S., Smith, P.M., and Yurochko, A.D. (2008a) Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol 181: 698-711.
17. Chan, G., Bivins-Smith, E.R., Smith, M.S., and Yurochko, A.D. (2008b) Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J Virol 82: 1040-1046.
18. Chan, G., Nogalski, M.T., and Yurochko, A.D. (2009) Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility. Proc Natl Acad Sci USA 106: 22369-22374.
19. Chan, G., Nogalski, M.T., Bentz, G.L., Smith, M.S., Parmater, A., and Yurochko, A.D. (2010) PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J Immunol 184: 3213-3222.
20. Chang, W.L., and Barry, P.A. (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity. Proc Natl Acad Sci USA 107: 22647-22652.
21. Cheung, A.K., Abendroth, A., Cunningham, A.L., and Slobedman, B. (2006) Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108: 3691-3699.
22. Cheung, A.K., Gottlieb, D.J., Plachter, B., Pepperl-Klindworth, S., Avdic, S., Cunningham, A.L., etal. (2009) The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114: 4128-4137.
23. Child, S.J., Hakki, M., De Niro, K.L., and Geballe, A.P. (2004) Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol 78: 197-205.
24. Cliffe, A.R., and Knipe, D.M. (2008) Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J Virol 82: 12030-12038.
25. Cliffe, A.R., Garber, D.A., and Knipe, D.M. (2009) Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters. J Virol 83: 8182-8190.
26. Dimitropoulou, P., Caswell, R., McSharry, B.P., Greaves, R.F., Spandidos, D.A., Wilkinson, G.W., and Sourvinos, G. (2010) Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging. Eur J Cell Biol 89: 757-768.
27. Drew, W.L., Tegtmeier, G., Alter, H.J., Laycock, M.E., Miner, R.C., and Busch, M.P. (2003) Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion 43: 309-313.
28. Everett, R.D., and Chelbi-Alix, M.K. (2007) PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89: 819-830.
29. Gao, J.L., and Murphy, P.M. (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269: 28539-28542.
30. Giordani, N.V., Neumann, D.M., Kwiatkowski, D.L., Bhattacharjee, P.S., McAnany, P.K., Hill, J.M., and Bloom, D.C. (2008) During herpes simplex virus type 1 infection of rabbits, the ability to express the latency-associated transcript increases latent-phase transcription of lytic genes. J Virol 82: 6056-6060.
31. Goodrum, F., Jordan, C.T., Terhune, S.S., High, K.P., and Shenk, T. (2004) Differential outcomes of human cytomegalovirus infection in primitive hematopoietic subpopulations. Blood 104: 687-695.
32. Goodrum, F., Reeves, M., Sinclair, J., High, K., and Shenk, T. (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110: 937-945.
33. Goodrum, F.D., Jordan, C.T., High, K., and Shenk, T. (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci USA 99: 16255-16260.
34. Grainger, L., Cicchini, L., Rak, M., Petrucelli, A., Fitzgerald, K.D., Semler, B.L., and Goodrum, F. (2010) Stress-inducible alternative translation initiation of human cytomegalovirus latency protein pUL138. J Virol 84: 9472-9486.
35. Grey, F., Antoniewicz, A., Allen, E., Saugstad, J., McShea, A., Carrington, J.C., and Nelson, J. (2005) Identification and characterization of human cytomegalovirus-encoded microRNAs. J Virol 79: 12095-12099.
36. Grey, F., Meyers, H., White, E.A., Spector, D.H., and Nelson, J. (2007) A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3: e163.
37. Gunther, T., and Grundhoff, A. (2010) The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.
38. Hansen, S.G., Powers, C.J., Richards, R., Ventura, A.B., Ford, J.C., Siess, D., etal. (2010) Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328: 102-106.
39. Hargett, D., and Shenk, T.E. (2010) Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci USA 107: 20039-20044.
40. Hwang, J., and Kalejta, R.F. (2007) Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367: 334-338.
41. Ishov, A.M., Vladimirova, O.V., and Maul, G.G. (2002) Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol 76: 7705-7712.
42. Jenkins, C., Abendroth, A., and Slobedman, B. (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78: 1440-1447.
43. Jones, M., Ladell, K., Wynn, K.K., Stacey, M.A., Quigley, M.F., Gostick, E., etal. (2010) IL-10 restricts memory T cell inflation during cytomegalovirus infection. J Immunol 185: 3583-3592.
44. Kaminskyy, V., and Zhivotovsky, B. (2010) To kill or be killed: how viruses interact with the cell death machinery. J Intern Med 267: 473-482.
45. Kern, E.R. (2006) Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antiviral Res 71: 164-171.
46. Knipe, D.M., and Cliffe, A. (2008) Chromatin control of herpes simplex virus lytic and latent infection. Nat Rev Microbiol 6: 211-221.
47. Kondo, K., Xu, J., and Mocarski, E.S. (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 93: 11137-11142.
48. Korioth, F., Maul, G.G., Plachter, B., Stamminger, T., and Frey, J. (1996) The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229: 155-158.
49. Kuhn, D.E., Beall, C.J., and Kolattukudy, P.E. (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211: 325-330.
50. Kung, C.P., Meckes, D.G., Jr, and Raab-Traub, N. (2011) Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J Virol 85: 4399-4408.
51. Kurz, S.K., Rapp, M., Steffens, H.P., Grzimek, N.K., Schmalz, S., and Reddehase, M.J. (1999) Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 73: 482-494.
52. Kwiatkowski, D.L., Thompson, H.W., and Bloom, D.C. (2009) The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J Virol 83: 8173-8181.
53. LaMarca, H.L., Nelson, A.B., Scandurro, A.B., Whitley, G.S., and Morris, C.A. (2006) Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta 27: 137-147.
54. Landini, M.P., Lazzarotto, T., Xu, J., Geballe, A.P., and Mocarski, E.S. (2000) Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol Blood Marrow Transplant 6: 100-108.
55. Le, V.T., Trilling, M., and Hengel, H. (2011) The cytomegaloviral protein pUL138 acts as potentiator of TNF receptor 1 surface density to enhance ULb′-encoded modulation of TNF-{alpha} signaling. J Virol 85: 13260-13270.
56. Li, R., Zhu, J., Xie, Z., Liao, G., Liu, J., Chen, M.R., etal. (2011) Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. Cell Host Microbe 10: 390-400.
57. Liu, X., Yuan, J., Wu, A.W., McGonagill, P.W., Galle, C.S., and Meier, J.L. (2010) Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells. J Virol 84: 8495-8508.
58. Lukashchuk, V., McFarlane, S., Everett, R.D., and Preston, C.M. (2008) Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J Virol 82: 12543-12554.
59. Marshall, E.E., Bierle, C.J., Brune, W., and Geballe, A.P. (2009) Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J Virol 83: 4112-4120.
60. Maul, G.G. (1998) Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20: 660-667.
61. Maul, G.G. (2008) Initiation of cytomegalovirus infection at ND10. Curr Top Microbiol Immunol 325: 117-132.
62. Meier, J.L., and Stinski, M.F. (2006) Major Immediate Early Enhancer and Its Gene Products. Norfolk, UK: Caister Academic Press, pp. 151-161.
63. Meyer, C., Grey, F., Kreklywich, C.N., Andoh, T.F., Tirabassi, R.S., Orloff, S.L., and Streblow, D.N. (2011) Cytomegalovirus microRNA expression is tissue specific and is associated with persistence. J Virol 85: 378-389.
64. Montag, C., Wagner, J.A., Gruska, I., Vetter, B., Wiebusch, L., and Hagemeier, C. (2011) The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. J Virol 85: 11409-11421.
65. Murphy, E., Vanicek, J., Robins, H., Shenk, T., and Levine, A.J. (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci USA 105: 5453-5458.
66. Murphy, J.C., Fischle, W., Verdin, E., and Sinclair, J.H. (2002) Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J 21: 1112-1120.
67. Nachmani, D., Lankry, D., Wolf, D.G., and Mandelboim, O. (2010) The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat Immunol 11: 806-813.
68. Nevels, M., Nitzsche, A., and Paulus, C. (2011) How to control an infectious bead string: nucleosome-based regulation and targeting of herpesvirus chromatin. Rev Med Virol 21: 154-180.
69. Nitzsche, A., Paulus, C., and Nevels, M. (2008) Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J Virol 82: 11167-11180.
70. Pannuti, C.S., Vilas Boas, L.S., Angelo, M.J., Amato Neto, V., Levi, G.C., de Mendonca, J.S., and de Godoy, C.V. (1985) Cytomegalovirus mononucleosis in children and adults: differences in clinical presentation. Scand J Infect Dis 17: 153-156.
71. Paulus, C., Nitzsche, A., and Nevels, M. (2010) Chromatinisation of herpesvirus genomes. Rev Med Virol 20: 34-50.
72. Pawelec, G., and Derhovanessian, E. (2011) Role of CMV in immune senescence. Virus Res 157: 175-179.
73. Petrucelli, A., Rak, M., Grainger, L., and Goodrum, F. (2009) Characterization of a novel Golgi-localized latency determinant encoded by human cytomegalovirus. J Virol 83: 5615-5629.
74. Poole, E., McGregor Dallas, S.R., Colston, J., Joseph, R.S., and Sinclair, J. (2011) Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34 progenitors. J Gen Virol 92: 1539-1549.
75. Powers, C., and Fruh, K. (2008) Rhesus CMV: an emerging animal model for human CMV. Med Microbiol Immunol 197: 109-115.
76. Powers, C., DeFilippis, V., Malouli, D., and Fruh, K. (2008) Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325: 333-359.
77. Preston, C.M., and Nicholl, M.J. (2006) Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87: 1113-1121.
78. Randolph-Habecker, J.R., Rahill, B., Torok-Storb, B., Vieira, J., Kolattukudy, P.E., Rovin, B.H., and Sedmak, D.D. (2002) The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine 19: 37-46.
79. Reddehase, M.J., Podlech, J., and Grzimek, N.K. (2002) Mouse models of cytomegalovirus latency: overview. J Clin Virol 25 (Suppl 2): S23-S36.
80. Reeves, M., Murphy, J., Greaves, R., Fairley, J., Brehm, A., and Sinclair, J. (2006) Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J Virol 80: 9998-10009.
81. Reeves, M., Woodhall, D., Compton, T., and Sinclair, J. (2010) Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. J Virol 84: 7185-7194.
82. Reeves, M.B., and Compton, T. (2011) Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 85: 12750-12758.
83. Reeves, M.B., and Sinclair, J.H. (2010) Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91: 599-604.
84. Reeves, M.B., MacAry, P.A., Lehner, P.J., Sissons, J.G., and Sinclair, J.H. (2005) Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 102: 4140-4145.
85. Reeves, M.B., Breidenstein, A., and Compton, T. (2012) Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc Natl Acad Sci USA 109: 588-593.
86. Reitsma, J.M., Savaryn, J.P., Faust, K., Sato, H., Halligan, B.D., and Terhune, S.S. (2011) Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest. Cell Host Microbe 9: 103-114.
87. Saffert, R.T., and Kalejta, R.F. (2006) Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80: 3863-3871.
88. Saffert, R.T., and Kalejta, R.F. (2007) Human cytomegalovirus gene expression is silenced by the Daxx-mediated intrinsic immune defense when model latent infections are established in vitro. J Virol 81: 9109-9120.
89. Saffert, R.T., Penkert, R.R., and Kalejta, R.F. (2010) Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J Virol 84: 5594-5604.
90. Sanchez, V., and Spector, D.H. (2008) Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol 325: 243-262.
91. Sato, Y., Shirata, N., Murata, T., Nakasu, S., Kudoh, A., Iwahori, S., etal. (2010) Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replication. Cell Cycle 9: 807-814.
92. Schleiss, M.R. (2006) Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J 47: 65-72.
93. Slinger, E., Maussang, D., Schreiber, A., Siderius, M., Rahbar, A., Fraile-Ramos, A., etal. (2010) HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 3: ra58.
94. Smith, M.S., Goldman, D.C., Bailey, A.S., Pfaffle, D.L., Kreklywich, C.N., Spencer, D.B., etal. (2010) Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8: 284-291.
95. Speck, S.H., and Ganem, D. (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8: 100-115.
96. Stagno, S., Reynolds, D.W., Pass, R.F., and Alford, C.A. (1980) Breast milk and the risk of cytomegalovirus infection. N Engl J Med 302: 1073-1076.
97. Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D.G., Saleh, N., Biton, M., etal. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
98. Stern-Ginossar, N., Saleh, N., Goldberg, M.D., Prichard, M., Wolf, D.G., and Mandelboim, O. (2009) Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83: 10684-10693.
99. Streblow, D.N., van Cleef, K.W., Kreklywich, C.N., Meyer, C., Smith, P., Defilippis, V., etal. (2007) Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J Virol 81: 3816-3826.
100. Streblow, D.N., Dumortier, J., Moses, A.V., Orloff, S.L., and Nelson, J.A. (2008) Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 325: 397-415.
101. Takacs, M., Banati, F., Koroknai, A., Segesdi, J., Salamon, D., Wolf, H., etal. (2010) Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim Biophys Acta 1799: 228-235.
102. Tan, J.C., Avdic, S., Cao, J.Z., Mocarski, E.S., White, K.L., Abendroth, A., and Slobedman, B. (2011) Inhibition of 2′, 5′-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol 85: 5696-5700.
103. Tavalai, N., and Stamminger, T. (2008) New insights into the role of the subnuclear structure ND10 for viral infection. Biochim Biophys Acta 1783: 2207-2221.
104. Tavalai, N., and Stamminger, T. (2011) Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res 157: 128-133.
105. Tavalai, N., Papior, P., Rechter, S., Leis, M., and Stamminger, T. (2006) Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol 80: 8006-8018.
106. Tavalai, N., Papior, P., Rechter, S., and Stamminger, T. (2008) Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol 82: 126-137.
107. Tavalai, N., Adler, M., Scherer, M., Riedl, Y., and Stamminger, T. (2011) Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol 85: 9447-9458.
108. Toth, Z., Maglinte, D.T., Lee, S.H., Lee, H.R., Wong, L.Y., Brulois, K.F., etal. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog 6: e1001013.
109. Umashankar, M., Petrucelli, A., Cicchini, L., Caposio, P., Kreklywich, C.N., Rak, M., etal. (2011) A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog 7: e1002444.
110. Umbach, J.L., Kramer, M.F., Jurak, I., Karnowski, H.W., Coen, D.M., and Cullen, B.R. (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454: 780-783.
111. Villarreal, L.P., Defilippis, V.R., and Gottlieb, K.A. (2000) Acute and persistent viral life strategies and their relationship to emerging diseases. Virology 272: 1-6.
112. Vomaske, J., Melnychuk, R.M., Smith, P.P., Powell, J., Hall, L., DeFilippis, V., etal. (2009) Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog 5: e1000304.
113. Wang, Q.Y., Zhou, C., Johnson, K.E., Colgrove, R.C., Coen, D.M., and Knipe, D.M. (2005) Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc Natl Acad Sci USA 102: 16055-16059.
114. Wang, X., Huong, S.M., Chiu, M.L., Raab-Traub, N., and Huang, E.S. (2003) Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424: 456-461.
115. White, K.L., Slobedman, B., and Mocarski, E.S. (2000) Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J Virol 74: 9333-9337.
116. Wills, M., Akbar, A., Beswick, M., Bosch, J.A., Caruso, C., Colonna-Romano, G., etal. (2011) Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing 8: 10.
117. Woodhall, D.L., Groves, I.J., Reeves, M.B., Wilkinson, G., and Sinclair, J.H. (2006) Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J Biol Chem 281: 37652-37660.
118. Yu, D., Silva, M.C., and Shenk, T. (2003) Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci USA 100: 12396-12401.
119. Yuan, J., Liu, X., Wu, A.W., McGonagill, P.W., Keller, M.J., Galle, C.S., and Meier, J.L. (2009) Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells. J Virol 83: 6391-6403.
120. Yurochko, A.D. (2008) Human cytomegalovirus modulation of signal transduction. Curr Top Microbiol Immunol 325: 205-220.
121. Zanghellini, F., Boppana, S.B., Emery, V.C., Griffiths, P.D., and Pass, R.F. (1999) Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180: 702-707.
122. Zydek, M., Hagemeier, C., and Wiebusch, L. (2010) Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog 6: e1001096.
123. Zydek, M., Uecker, R., Tavalai, N., Stamminger, T., Hagemeier, C., and Wiebusch, L. (2011) General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism. J Gen Virol 92: 2757-2769.